Engineering Periodic shRNA for Enhanced Silencing Efficacy. - Wikidata - awgldk - TriplyDB

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

http://www.wikidata.org/entity/Q37043521

about

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

http://www.wikidata.org/entity/Q37043521

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

@en

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

@nl

type

label

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

@en

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

@nl

prefLabel

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

@en

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

@nl

P1433

Q37043521-D21E60C2-FBC6-4308-8653-E4927EE3995B

P1476

Q37043521-74C55AB1-2A2A-4527-9638-82E7F8912F07

P2093

Q37043521-54629221-8308-4C2C-8794-6271E95F6C1C

Q37043521-748DD659-B095-403F-9CFF-51A4A0A00B01

P2860

Q37043521-041FCBA6-3A7E-4925-B162-2B84903320EE

Q37043521-06581497-05E7-4467-A3FA-DB0904713A8B

Q37043521-0AFA0C41-C5CF-47C4-A51F-4BAEFDD3359C

Q37043521-1F3B7C36-55AF-44CA-AA5C-75F6955BC1FE

Q37043521-2DB2AEE4-F64F-4545-BEE4-AC603129A585

Q37043521-3276D287-42AA-44BC-A089-BA5FF59F1846

Q37043521-38919208-6530-4E33-AA93-8EBFD27EAFCA

Q37043521-52AE30E7-9D48-45B2-A4B5-A059B400B7AA

Q37043521-761B4CCF-6CAD-44F2-B71E-7C736CC0B4EF

Q37043521-7765FC19-1B2E-4F88-91BB-DA20E9527826

P304

Q37043521-E4155327-BEC4-4F12-B24E-7E0DF01B0940

P31

Q37043521-2A58E7F8-EEE0-4BC1-A9C0-DA391CD01829

P356

Q37043521-8B5A0662-4891-4D01-9EEA-368AB028A465

P433

Q37043521-1FE4755A-52B9-4AC3-8927-DF4C8B163931

P478

Q37043521-AB31EA3A-84C2-4CD6-86CF-CEC57A104FD9

P50

Q37043521-F438D06A-5435-4DA2-9BB9-AC2FBAA81117

P577

Q37043521-CC96715B-A0CB-4608-955C-0D36AFB6473E

P698

Q37043521-635A0EFB-E83A-411C-8521-C742E9D5ECC4

P932

Q37043521-CB2F0962-D7BF-4722-B424-E0A3A0577E26

P356

P1433

Molecular Therapy

P1476

Engineering Periodic shRNA for Enhanced Silencing Efficacy.

@en

P2093

Connie Wu

http://www.w3.org/2001/XMLSchema#string

Kevin E Shopsowitz

http://www.w3.org/2001/XMLSchema#string

P2860

The emerging field of RNA nanotechnology

Knocking down disease: a progress report on siRNA therapeutics

Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine.

RNAi-microsponges form through self-assembly of the organic and inorganic products of transcription.

RNAi therapies: drugging the undruggable.

Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane.

Sticky overhangs enhance siRNA-mediated gene silencing.

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine

Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells

Principles of nanoparticle design for overcoming biological barriers to drug delivery

P304

1070-1077

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2016.69

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Paula T. Hammond

P577

2016-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27053374

http://www.w3.org/2001/XMLSchema#string

P932

4923333

http://www.w3.org/2001/XMLSchema#string